We are thrilled to share that Drug Discovery World’s 2025 Predictions Feature has now been published in its Winter Issue —and it includes insights from Natalia Elizalde, Chief Business Development Officer at VIVEbiotech.
In the article, Natalia discusses the exciting future of cell and gene therapy (CGT), highlighting:
- The growing use of lentiviral vector-based technologies.
- Breakthroughs in in-vivo therapies and CAR-T applications.
- Expanding possibilities for treating autoimmune disorders and solid tumors.
Her expert commentary reflects the innovation shaping the CGT landscape in 2025.
The full feature is on pages 7-11 of the following link, with Natalia’s contribution on page 10— a must-read for anyone passionate about the future of the industry: https://www.ddw-online.com/ddw-winter-2024-2025-33097-202501/